Effect Analysis of Intravenous Thrombolysis with Alpinase Combined with Shuxuening Injection on Acute Ischemic Stroke  

作　　者：LUYe 

机构地区：[1]HebeiYouaiHospital,Shijiazhuang050000,China

出　　处：《外文科技期刊数据库(文摘版)医药卫生》2022年第10期071-075,共5页

摘　　要：Objective: to observe the clinical effect of intravenous thrombolysis with alteplase combined with Shuxuening injection on ischemic stroke. Methods: selected subjects: 90 patients with acute ischemic stroke in the emergency department of our hospital were selected from March 2021 to August 2022. They were grouped according to the computer parity distribution method, the control group database (45 patients data), and the observation group database (43 patients data), and Shuxuening injection combined with alteplase therapy. To observe the effects of different therapies on the clinical effect, neurological function score, inflammatory value, neurotransmitter and coagulation value of patients. Results: compared with the parameter difference between groups, there was no significant difference in data before treatment (P > 0.05). After treatment, the results of data comparison were significant, the clinical treatment effect of the patients in the observation group was significantly improved, the inflammatory values and neurological function scores were significantly decreased, and the neurotransmitters and coagulation values were significantly improved, P<0.05. Conclusion: the combined therapy of intravenous thrombolysis with alteplase and Shuxuening injection for patients with acute ischemic stroke has a significant clinical effect, which can effectively change the patients condition and improve the inflammatory response and neurological function.

关 键 词：intravenous thrombolysis with alteplase Shuxuening injection acute ischemic stroke clinical effec 

分 类 号：R743.3[医药卫生—神经病学与精神病学]